Article Details

Biotech firm Roivant Sciences to go public via $7.3 billion SPAC deal

Retrieved on: 2021-05-03 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Biotech firm Roivant Sciences to go public via $7.3 billion SPAC deal. View article details on hiswai:

Excerpt

... existing investors including Fidelity Management and SoftBank Group Corp ... SPACs are shell companies that raise funds through an IPO to take a ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up